Windtree Therapeutics Inc

NASDAQ:WINT   10:21:35 AM EDT
0.46
+0.01 (+1.32%)
Earnings Announcements

Windtree Therapeutics Reports Q4 Results

Published: 03/31/2022 12:36 GMT
Windtree Therapeutics Inc (WINT) - Reported Qtrly Net Loss of $0.46 per Basic Share.
Revenue is expected to be $0.3 Million
Adjusted EPS is expected to be -$0.19

Next Quarter Revenue Guidance is expected to be $0.5 Million
Next Quarter EPS Guidance is expected to be -$0.19

More details on our Analysts Page.